The Francis Crick Institute is delighted to host this half-day summit for scientists, investors and entrepreneurs on steeping up biotech partnering to make greater impact on health and wealth.
13.30-14.00 Registration
14.00 - 14.10 Welcome
Veronique Birault, Head of Translation, The Francis Crick Institute
Miranda Weston-Smith, Founder, BioBeat
14.10 - 14.35 Partnering Case Study at the Crick
Chair: Tamsin Sayer, Head of Collaboration, The Francis Crick Institute
Lucy Collinson, Head of Electron Microscopy, The Francis Crick Institute
14.40 - 15.30 Catalysing biotech partnering opportunities
Chair: Veronique Birault, Head of Translation, The Francis Crick Institute
On the panel: Lucinda Crabtree, Senior Investment Analyst, Woodford Patient Capital, Jane Dancer, CBO, F-Star Biotechnology, Sarah Howell, CEO, Arecor, Natalie Mount, CSO, GammaDelta Therapeutics
15.30 - 16.00 Tea and coffee
16.00 -17.00 Partnering and careers permeability
Chair: Kate Bingham, Managing Partner, SV Life Sciences
On the panel: Barbara Domayne-Hayman, CBO, Autifony and Chair, Puridify, Julie Simmonds, Director, Equity Research, Panmure Gordon, Carmel Reilly, CEO, NeuroCentrx Pharma, Andrea Spezzi, CMO and Co-founder, Orchard Therapeutics, Angela Russell, Associate Professor Medicinal Chemistry, University of Oxford and Co-founder, OxStem
17.00 -18.30 Drinks and networking
13.30-14.00 Registration
14.00 - 14.10 Welcome
Veronique Birault, Head of Translation, The Francis Crick Institute
Miranda Weston-Smith, Founder, BioBeat
14.10 - 14.35 Partnering Case Study at the Crick
Chair: Tamsin Sayer, Head of Collaboration, The Francis Crick Institute
Lucy Collinson, Head of Electron Microscopy, The Francis Crick Institute
14.40 - 15.30 Catalysing biotech partnering opportunities
Chair: Veronique Birault, Head of Translation, The Francis Crick Institute
On the panel: Lucinda Crabtree, Senior Investment Analyst, Woodford Patient Capital, Jane Dancer, CBO, F-Star Biotechnology, Sarah Howell, CEO, Arecor, Natalie Mount, CSO, GammaDelta Therapeutics
15.30 - 16.00 Tea and coffee
16.00 -17.00 Partnering and careers permeability
Chair: Kate Bingham, Managing Partner, SV Life Sciences
On the panel: Barbara Domayne-Hayman, CBO, Autifony and Chair, Puridify, Julie Simmonds, Director, Equity Research, Panmure Gordon, Carmel Reilly, CEO, NeuroCentrx Pharma, Andrea Spezzi, CMO and Co-founder, Orchard Therapeutics, Angela Russell, Associate Professor Medicinal Chemistry, University of Oxford and Co-founder, OxStem
17.00 -18.30 Drinks and networking
